Privately-held German radiopharmaceutical company Isotope Technologies Munich (ITM) has announced the appointment of Celine ...

Family-controlled Spanish pharma company Esteve has signed a license and supply agreement with Eton Pharmaceuticals (Nasdaq: ...

US biotech AIRNA has raised $155 million in series B funding to advance its lead RNA-editing therapy into human trials and ...

Olga Uspenskaya-Cado has been named chief medical officer (CMO) of VectorY Therapeutics, a privately-held Dutch biotech ...

US drug developer Palatin Technologies (NYSE American: PTN) announced that its BMT-801 Phase II obesity co-administration ...

UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...

Nuage Therapeutics, a Barcelona-based biotech specializing in precision therapies for cancer, has appointed Stuart Hughes as chief executive and Vanessa Malier as chair of the board. Mr Hughes ...

US oncology biotech Inspirna is winding down after a decade of operations, according to a LinkedIn post from chief executive Usman Azam. He said the New York-based company would close after “ten ...

Positive results from the PURSUIT Phase IIb trial of AstraZeneca’s AZD0780 have shown a statistically significant low-density ...

New data from Israel-based generics giant Teva Pharmaceutical Industries (NYSE: TEVA) show favorable patient and healthcare ...

China's Bio-Thera Solutions has entered into an exclusive commercialization agreement with India's Dr. Reddy's Laboratories ...

Merck & Co has announced the first presentation of full results from the Phase III ZENITH trial of Winrevair ...